Newslines lets you create cool news timelines about your favorite people and products. Register now!
Federal Food & Drug Administration Neupro Parkinson's disease

FDA approval

9 May, 2007

The FDA announces the approval of Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease.┬áNeupro patches, which are changed daily, deliver rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.